vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and STAAR SURGICAL CO (STAA). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $49.0M, roughly 1.9× STAAR SURGICAL CO). STAAR SURGICAL CO runs the higher net margin — -69.9% vs -98.1%, a 28.2% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -35.8%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs -18.4%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

STAAR Surgical Co is a global ophthalmic medical device firm. It designs, makes and sells implantable collamer lenses (ICLs) for minimally invasive vision correction, plus supporting surgical products for ophthalmologists across North America, Europe, Asia Pacific and other key regional markets.

HIVE vs STAA — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.9× larger
HIVE
$93.1M
$49.0M
STAA
Growing faster (revenue YoY)
HIVE
HIVE
+254.4% gap
HIVE
218.6%
-35.8%
STAA
Higher net margin
STAA
STAA
28.2% more per $
STAA
-69.9%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
-18.4%
STAA

Income Statement — Q3 FY2026 vs Q4 FY2024

Metric
HIVE
HIVE
STAA
STAA
Revenue
$93.1M
$49.0M
Net Profit
$-91.3M
$-34.2M
Gross Margin
-27.1%
64.7%
Operating Margin
-57.0%
Net Margin
-98.1%
-69.9%
Revenue YoY
218.6%
-35.8%
Net Profit YoY
-234.0%
-541.3%
EPS (diluted)
$-0.38
$-0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
STAA
STAA
Q4 25
$93.1M
Q3 25
$87.3M
Q2 25
$45.6M
Q4 24
$29.2M
$49.0M
Q3 24
$22.6M
$88.6M
Q2 24
$32.2M
$99.0M
Q1 24
$77.4M
Q4 23
$22.8M
$76.3M
Net Profit
HIVE
HIVE
STAA
STAA
Q4 25
$-91.3M
Q3 25
$-15.8M
Q2 25
$35.0M
Q4 24
$68.2M
$-34.2M
Q3 24
$80.0K
$10.0M
Q2 24
$-18.3M
$7.4M
Q1 24
$-3.3M
Q4 23
$-24.5M
$7.8M
Gross Margin
HIVE
HIVE
STAA
STAA
Q4 25
-27.1%
Q3 25
4.7%
Q2 25
-13.6%
Q4 24
-43.7%
64.7%
Q3 24
-66.1%
77.3%
Q2 24
-7.4%
79.2%
Q1 24
78.9%
Q4 23
-52.3%
79.6%
Operating Margin
HIVE
HIVE
STAA
STAA
Q4 25
Q3 25
Q2 25
Q4 24
-57.0%
Q3 24
6.4%
Q2 24
12.0%
Q1 24
-2.9%
Q4 23
13.6%
Net Margin
HIVE
HIVE
STAA
STAA
Q4 25
-98.1%
Q3 25
-18.1%
Q2 25
76.8%
Q4 24
233.2%
-69.9%
Q3 24
0.4%
11.3%
Q2 24
-56.7%
7.5%
Q1 24
-4.3%
Q4 23
-107.8%
10.2%
EPS (diluted)
HIVE
HIVE
STAA
STAA
Q4 25
$-0.38
Q3 25
$-0.07
Q2 25
$0.18
Q4 24
$0.52
$-0.69
Q3 24
$0.00
$0.20
Q2 24
$-0.17
$0.15
Q1 24
$-0.07
Q4 23
$-0.29
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
STAA
STAA
Cash + ST InvestmentsLiquidity on hand
$230.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$397.3M
Total Assets
$624.0M
$509.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
STAA
STAA
Q4 25
Q3 25
Q2 25
Q4 24
$40.5M
$230.5M
Q3 24
$31.7M
$236.0M
Q2 24
$235.2M
Q1 24
$245.1M
Q4 23
$4.5M
$220.7M
Stockholders' Equity
HIVE
HIVE
STAA
STAA
Q4 25
$559.3M
Q3 25
$624.6M
Q2 25
$560.5M
Q4 24
$430.9M
$397.3M
Q3 24
$275.5M
$428.1M
Q2 24
$268.6M
$409.1M
Q1 24
$392.8M
Q4 23
$122.9M
$386.0M
Total Assets
HIVE
HIVE
STAA
STAA
Q4 25
$624.0M
Q3 25
$693.0M
Q2 25
$628.7M
Q4 24
$478.6M
$509.5M
Q3 24
$334.7M
$537.6M
Q2 24
$512.7M
Q1 24
$492.5M
Q4 23
$488.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
STAA
STAA
Operating Cash FlowLast quarter
$46.0M
$642.0K
Free Cash FlowOCF − Capex
$-5.1M
FCF MarginFCF / Revenue
-10.4%
Capex IntensityCapex / Revenue
11.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
STAA
STAA
Q4 25
$46.0M
Q3 25
$-10.6M
Q2 25
$10.2M
Q4 24
$-28.5M
$642.0K
Q3 24
$-2.2M
$3.8M
Q2 24
$-4.4M
$-10.4M
Q1 24
$21.7M
Q4 23
$32.0M
Free Cash Flow
HIVE
HIVE
STAA
STAA
Q4 25
Q3 25
Q2 25
Q4 24
$-55.5M
$-5.1M
Q3 24
$-34.7M
$-2.4M
Q2 24
$-16.6M
Q1 24
$16.5M
Q4 23
$28.9M
FCF Margin
HIVE
HIVE
STAA
STAA
Q4 25
Q3 25
Q2 25
Q4 24
-189.9%
-10.4%
Q3 24
-153.4%
-2.7%
Q2 24
-16.8%
Q1 24
21.3%
Q4 23
37.9%
Capex Intensity
HIVE
HIVE
STAA
STAA
Q4 25
Q3 25
Q2 25
Q4 24
92.5%
11.7%
Q3 24
143.9%
7.0%
Q2 24
6.3%
Q1 24
6.7%
Q4 23
4.0%
Cash Conversion
HIVE
HIVE
STAA
STAA
Q4 25
Q3 25
Q2 25
0.29×
Q4 24
-0.42×
Q3 24
-26.94×
0.38×
Q2 24
-1.41×
Q1 24
Q4 23
4.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons